USPTO serial 79191246
INFLAMMACHECK
Reviewed by CopyMark Law Group
Reg. 5253161Status 706Renewal
- Filing date
- Status date
- Registration date
- Aug 1, 2017
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with INFLAMMACHECK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew A. Homyk
Matthew A. Homyk Blank Rome LLPOne Logan SquarePhiladelphia, PA 19103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments in the nature of apparatus for the alleviation of breathing difficulties, namely, handheld diagnostic apparatus capable of analyzing exhalate and breath condensates with inbuilt software recommending what crisis treatment necessary to alleviate breathing difficulties being experienced by a patient; apparatus for use in collecting exhaled breath, namely, exhaled breath sample collection, analysis and reader instrumentation housed within a portable handheld unit and operating software sold therewith as a unit for use in the diagnosis of COPD crisis, COPD exacerbations, asthma events, pulmonary crisis events and the identification of condensates signaling the occurrence of a medical crisis; apparatus for use in analysing exhaled breath; apparatus for use in medical analysis, namely, computerized recording and analysis instrumentation for the diagnosis and treatment of respiratory conditions for medical use; medical apparatus for use in the investigation of metabolic disorders, namely, computerized recording and analysis instrumentation for the monitoring of metabolic functions; body rehabilitation apparatus for medical purposes; breath condensate and gas analysers for medical diagnostics; cases fitted for medical instruments; diagnostic apparatus for medical purposes, namely, instrumentation for monitoring heart rate, pulse oxymetary, breathing, gas analysis and respiratory events; [ medical instrumentation for monitoring heart rate, pulse oxymetary, breathing, gas analysis and respiratory events and software sold therewith as a portable handheld unit for medical use; medical diagnostic instruments sold in the form of kits comprised of breath and exhalate condensate specimen collection and identification kit and instructions, all for medical use by patients, their care givers and medical professionals in relation to breathing, gas analysis and respiratory events; ] medical testing apparatus and instruments for the detection of respiratory disorders sold as kits; medical apparatus for controlling pulmonary gas exchange parameters; medical apparatus for assisting breathing, namely, patient breathing system comprising artificial respiration apparatus for medical use; pulmonary diagnostic apparatus and instrumentation, namely, diagnostic instrumentation used for the detection of breathing anomalies, pulmonary function, pulmonary dysfunction and respiratory events for medical use; pulmonary function testing apparatus and instrumentation, namely, handheld breathing testing machines, handheld pulmonary function and pulmonary dysfunction testing machines for medical use; respiratory apparatus and instrumentation, namely, hand-held patient respiratory analysis equipment, and medical devices, namely, patient monitors and patient sensors for monitoring respiratory events; respiratory monitors for medical use; respiratory therapy apparatus and instrumentation, namely, medical instrumentation for diagnosing respiratory conditions, medical instrumentation for treating respiratory conditions; Probes for medical purposes, excluding probes used for blood glucose monitoring or diabetes care; probes for diagnostic purposes, excluding probes used for blood glucose monitoring or diabetes care; tools for medical diagnostics, namely, diagnostic instrumentation and software sold therewith as a handheld portable unit for medical use, excluding diagnostic instrumentation and software used for blood glucose monitoring or diabetes care; replacement parts and fittings for the aforesaid goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Exhalation Technology Ltd
- Other trademarks owned by Exhalation Technology Ltd
- Other trademarks owned by Exhalation Technology Ltd
- Other trademarks in Class 010
- Similar marks named INFLAMMACHECK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jul 28, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 12, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Nov 28, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Nov 28, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jul 25, 2025 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jan 29, 2025 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| May 30, 2024 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| May 15, 2024 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Apr 8, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 31, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 1, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 20, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 2, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 24, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 3, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 3, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 1, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 1, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 27, 2017 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 7, 2017 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jun 7, 2017 | APET | ASSIGNED TO PETITION STAFF | — |
| Jun 2, 2017 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Mar 16, 2017 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 14, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 14, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 10, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 22, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 22, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 22, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 3, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 23, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 21, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 21, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2016 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 19, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 19, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 17, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 16, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 8, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |